Patents by Inventor Jason David Howard

Jason David Howard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADENOCARCINOMA ANTIGENIC DETERMINANTS AND METHODS
    Publication number: 20170226171
    Abstract: Adenocarcinoma antigenic determinants, methods for their production and use, and broadly-specific human monoclonal antibodies reactive to the epitopes. These epitopes, which can be physically recapitulated, are conserved across a range of adenocarcinomas and are capable of eliciting an immune response in humans.
    Type: Application
    Filed: April 4, 2016
    Publication date: August 10, 2017
    Applicant: Vaccinogen, Inc.
    Inventors: Michael George Hanna, JR., Jason David Howard
  • IDENTIFICATION OF THE GENE NOTCH3 AS A NOVEL BIOMARKER FOR HUMAN METASTATIC MELANOMA
    Publication number: 20130095493
    Abstract: The present invention provides evidence that Notch3 gene upregulation is associated with invasive metastatic melanoma. Assays for quantifying Notch3 expression in biological samples and methods of use for diagnosis, and assaying progression and treatment outcome using these assays are also provided. Methods of screening for compounds which inhibit Notch3 expression are also provided.
    Type: Application
    Filed: October 3, 2012
    Publication date: April 18, 2013
    Applicant: THE JOHNS HOPKINS UNIVERSITY
    Inventors: Rhoda Myra Alani, Jason David Howard